FDA Issues Complete Response Letter to Saol for SL1009 (DCA)
08 Sep 2025 //
PR NEWSWIRE
Saol`s SL1009 NDA Accepted for Pyruvate Dehydrogenase Deficiency
28 Jan 2025 //
PR NEWSWIRE
Keeping Cancer Out of Breath Blocks Drug Resistance
27 Aug 2018 //
R&DMAG